Heptadecanoic acid
|
Basic information |
| Metabolite name | Heptadecanoic acid |
 | HMDB0002259 |
 |
N/A |
 |
10465 |
| Synonyms | Heptadecylic acid; |
| No. of studies | 13 |
|
Basic information |
| Metabolite name | Heptadecanoic acid |
| HMDB0002259 |
|
N/A |
|
10465 |
| Synonyms | Heptadecylic acid; |
| No. of studies | 13 |
|
Relationship between Heptadecanoic acid and depression (count: 13) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M040 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M084 | Type1 | melancholic depressed group vs. control group | Plasma | Human | Unknown |
| Study M1090 | Type3 | hyperbaric oxygen treatment group vs. control group | Plasma | BALb/c mouse | Up |
| Study M1111 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6 mouse | Down |
| Study M116 | Type3 | LY group vs. control group | Cerebrospinal fluid | Sprague-Dawley rat | Up |
| Study M536 | Type1 | naturally-occurring depression group vs. control group | Cerebrospinal fluid | Cynomolgus monkey | Up |
| Study M712 | Type1 | depression group vs. control group | Amygdala | Cynomolgus monkey | Down |
| Study M771 | Type1 | CSDS group vs. control group | Faece | C57BL/6J mouse | Up |
| Study M772 | Type1 | CUMS group vs. control group | Amygdala | Sprague-Dawley rat | Up |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Down |
| Study M870 | Type1 | CRS group vs. control group | Brain | C57BL/6 mouse | Down |
| Study M907 | Type1 | MDD group vs. control group | Plasma | Human | Up |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Down |